EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cannabidiol Enhances Cabozantinib-Induced Apoptotic Cell Death via Phosphorylation of p53 Regulated by ER Stress in Hepatocellular Carcinoma

Youngsic Jeon, Taejung Kim iD, Hyukjoon Kwon, Jeong-Kook Kim, Young-Tae Park iD, Jungyeob Ham iD, Young-Joo Kim iD

Cancers · 05.08.2023 · 15 (15) · 3987

DOI: 10.3390/cancers15153987 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 05.08.2023. Verfasst von Youngsic Jeon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Natural Products Research Center, Korea Institute of Science and Technology, Gangneung 25451, Republic of Korea. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Institute of Science and Technology, Ministry of Science and ICT, Ministry of SMEs and Startups (MMS, Republic of Korea).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cannabidiol (CBD), a primary constituent in hemp and cannabis, exerts broad pharmacological effects against various diseases, including cancer. Additionally, cabozantinib, a potent multi-kinase inhibitor, has been approved for treating patients with advanced hepatocellular carcinoma (HCC). Recently, there has been an increase in research on combination therapy using cabozantinib to improve efficacy and safety when treating patients. Here, we investigated the effect of a combination treatment of cabozantinib and CBD on HCC cells. CBD treatment enhanced the sensitivity of HCC cells to cabozantinib-mediated anti-cancer activity by increasing cytotoxicity and apoptosis. Phospho-kinase array analysis demonstrated that the apoptotic effect of the combination treatment was mainly related to p53 phosphorylation regulated by endoplasmic reticulum (ER) stress when compared to other kinases. The inhibition of p53 expression and ER stress suppressed the apoptotic effect of the combination treatment, revealing no changes in the expression of Bax, Bcl-2, cleaved caspase-3, cleaved caspase-8, or cleaved caspase-9. Notably, the effect of the combination treatment was not associated with cannabinoid receptor 1 (CNR1) and the CNR2 signaling pathways. Our findings suggest that the combination therapy of cabozantinib and CBD provides therapeutic efficacy against HCC.

Schlagwörter

Stichwörter der Autor:innen

apoptosiscabozantinibcannabidiolendoplasmic reticulum stressp53

Autor:innen und Institutionen

  • Natural Products Research Center, Korea Institute of Science and Technology, Gangneung 25451, Republic of Korea.
  • Division of Bio-Medical Science & Technology, KIST School, University of Science and Technology, Seoul 02792, Republic of Korea.
  • NeoCannBio Co., Ltd., Seoul 02792, Republic of Korea.

ORCID-Profile: Taejung Kim, Young-Tae Park, Jungyeob Ham, Young-Joo Kim

Förderung

  • Korea Institute of Science and Technology
  • Ministry of Science and ICT
  • Ministry of SMEs and Startups (MMS, Republic of Korea)

Zitieren

APA

Jeon, Y., Kim, T., Kwon, H., Kim, J. K., Park, Y. T., Ham, J., & Kim, Y. J. (2023). Cannabidiol Enhances Cabozantinib-Induced Apoptotic Cell Death via Phosphorylation of p53 Regulated by ER Stress in Hepatocellular Carcinoma. Cancers, 15(15), 3987. https://doi.org/10.3390/cancers15153987

Vancouver

Jeon Y, Kim T, Kwon H, Kim JK, Park YT, Ham J, et al. Cannabidiol Enhances Cabozantinib-Induced Apoptotic Cell Death via Phosphorylation of p53 Regulated by ER Stress in Hepatocellular Carcinoma. Cancers. 2023;15(15):3987. doi:10.3390/cancers15153987

BibTeX
@article{Jeon2023,
  author = {Jeon, Youngsic and Kim, Taejung and Kwon, Hyukjoon and Kim, Jeong-Kook and Park, Young-Tae and Ham, Jungyeob and Kim, Young-Joo},
  title = {Cannabidiol Enhances Cabozantinib-Induced Apoptotic Cell Death via Phosphorylation of p53 Regulated by ER Stress in Hepatocellular Carcinoma},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {15},
  pages = {3987},
  doi = {10.3390/cancers15153987}
}
Kostenlos starten →